Wayne P. Rothbaum - Net Worth and Insider Trading
Wayne P. Rothbaum Net Worth
The estimated net worth of Wayne P. Rothbaum is at least $264 Million dollars as of 2024-11-29. Wayne P. Rothbaum is the Director of Iovance Biotherapeutics Inc and owns about 28,067,333 shares of Iovance Biotherapeutics Inc (IOVA) stock worth over $264 Million. Details can be seen in Wayne P. Rothbaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wayne P. Rothbaum has not made any transactions after 2024-02-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wayne P. Rothbaum
Wayne P. Rothbaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wayne P. Rothbaum owns 1 companies in total, including Iovance Biotherapeutics Inc (IOVA) .
Click here to see the complete history of Wayne P. Rothbaum’s form 4 insider trades.
Insider Ownership Summary of Wayne P. Rothbaum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2024-02-20 | director |
Wayne P. Rothbaum Latest Holdings Summary
Wayne P. Rothbaum currently owns a total of 1 stock. Wayne P. Rothbaum owns 28,067,333 shares of Iovance Biotherapeutics Inc (IOVA) as of February 20, 2024, with a value of $264 Million.
Latest Holdings of Wayne P. Rothbaum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| IOVA | Iovance Biotherapeutics Inc | 2024-02-20 | 28,067,333 | 9.40 | 263,832,930 |
Holding Weightings of Wayne P. Rothbaum
Wayne P. Rothbaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Wayne P. Rothbaum has made a total of 4 transactions in Iovance Biotherapeutics Inc (IOVA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Iovance Biotherapeutics Inc is the acquisition of 5,000,000 shares on February 20, 2024, which cost Wayne P. Rothbaum around $46 Million.
Insider Trading History of Wayne P. Rothbaum
- 1
Wayne P. Rothbaum Trading Performance
GuruFocus tracks the stock performance after each of Wayne P. Rothbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wayne P. Rothbaum is 22.27%. GuruFocus also compares Wayne P. Rothbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wayne P. Rothbaum within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wayne P. Rothbaum's insider trading performs compared to the benchmark.
Performance of Wayne P. Rothbaum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.39 | | | | | |
| Relative Return to S&P 500(%) | 15.64 | | | | | |
Wayne P. Rothbaum Ownership Network
Wayne P. Rothbaum Owned Company Details
What does Iovance Biotherapeutics Inc do?
Who are the key executives at Iovance Biotherapeutics Inc?
Wayne P. Rothbaum is the director of Iovance Biotherapeutics Inc. Other key executives at Iovance Biotherapeutics Inc include General Counsel Frederick G Vogt , Chief Operating Officer Igor Bilinsky , and Chief Financial Officer Jean-marc Bellemin .
Iovance Biotherapeutics Inc (IOVA) Insider Trades Summary
Over the past 18 months, Wayne P. Rothbaum made 2 insider transaction in Iovance Biotherapeutics Inc (IOVA) with a net purchase of 10,000,000. Other recent insider transactions involving Iovance Biotherapeutics Inc (IOVA) include a net purchase of 260,000 shares made by Merrill A Mcpeak , a net sale of 50,000 shares made by Ryan D Maynard ,
In summary, during the past 3 months, insiders sold 50,000 shares of Iovance Biotherapeutics Inc (IOVA) in total and bought 0 shares, with a net sale of 50,000 shares. During the past 18 months, 50,000 shares of Iovance Biotherapeutics Inc (IOVA) were sold and 10,260,000 shares were bought by its insiders, resulting in a net purchase of 10,210,000 shares.
Iovance Biotherapeutics Inc (IOVA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iovance Biotherapeutics Inc Insider Transactions
Wayne P. Rothbaum Mailing Address
Above is the net worth, insider trading, and ownership report for Wayne P. Rothbaum. You might contact Wayne P. Rothbaum via mailing address: C/o Quogue Capital Llc, 1285 Avenue Of The Americas, 35th Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
